Fig. 6From: 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice1,25-dihydroxyvitamin D3 inhibited the NF-κB/MAPKs signaling pathways. A The mRNA levels by RT-PCR. B, C The protein levels by Western blot, bands 1–8 represent the control groups at 14, 16, 18, 20 weeks and the VitD3-treated groups at 14, 16, 18, 20 weeks respectively. The samples derive from the same experiment and the gels/blots were processed in parallel. Data are presented as means ± SD (n = 3/group). * VS. the control group at the same time. # VS. the control group at 14 weeks. △VS. the treated group at 14 weeks. *#△ p < 0.05, **##△△p < 0.01, ***###△△△p < 0.001, ****####△△△△p < 0.0001Back to article page